乳糜性腹水诊治现状*

doi:10.3969/j.issn.1672-5069.2018.05.003

Abstract

Li Yue, Ding Huiguo.. Current diagnosis and treatment of chylous ascites[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 665-668.

[1] Lizaola B,Bonder A,Trivedi HD,et al.The diagnostic approach and current management of chylous ascites. Aliment Pharmacol Ther 2017,46(9):816-824.
[2] Mukherjee A,Sehgal IS,Mittal BR,et al. Transudative chylothorax:an uncommon illness due to a common cause. BMJ Case Rep,2018[ahead of print].
[3] Doerr CH,Allen MS,Nichols FC III,et al.Etiology of chylothorax in 203 patients. Mayo Clin Proc,2005,80:867-870.[4] Browse NL,Wilson NM,Russo F,et al. Aetiology and treatment of chylous ascites. Br J Surg,1992,79:1145-1150.
[5] Ur Rahman A,Ramaraj R,Humphreys E,et al.Retroperitoneal fibrosis as a cause of chylous ascites. ACG Case Rep J,2017,4:e115.
[6] Talluri SK,Nuthakki H,Tadakamalla A,et al.Chylous ascites. N Am J Med Sci,2011,3(9):438-440.
[7] Steinemann DC,Dindo D,Clavien PA,et al.Atraumatic chylous ascites:systematic review on symptoms and causes. J Am Coll Surg,2011,212:899-905.
[8] Yau KK,Siu WT,Li MK.Chylous ascites in a patient with esophageal carcinoma. Clin Gastroenterol Hepatol,2005,3:A33.
[9] Runyon BA,Hoefs JC,Morgan TR.Ascitic fluid analysis in malignancy-related ascites. Hepatology,1988,8:1104-1109.
[10] Romero S,Martin C,Hernandez L,et al.Chylothorax in cirrhosis of the liver:analysis of its frequency and clinical characteristics. Chest,1998,114:154-159.
[11] Rabie H,Lomp A,Goussard P,et al.Paradoxical tuberculosis associated immune reconstitution inflammatory syndrome presenting with chylous ascites and chylothorax in a HIV-1 infected child. J Trop Pediatr,2010,56(5):355-358.
[12] Vignes S,Bellanger J.Primary intestinal lymphangiectasia (Waldmann’s disease). Orphanet J Rare Dis,2008,3:5.
[13] Duhra PM,Quigley EM,Marsh MN.Chylous ascites,intestinal lymphangiectasia and the‘yellow-nail’ syndrome. Gut,1985,26:1266-1269.
[14] Scribner DR Jr,Lara-Torre E,Heineck RJ,et al.Klippel-Trenaunay syndrome complicated by ascites and vaginal lymphatic drainage in adolescence:a case report. J Pediatr Adolesc Gynecol,2012,25:e139-e141.
[15] Nerune SM,Arakeri SU,Patil VL,et al. Bilateral cystic lymphangioma of ovary associated with chylous ascites. J Clin Diagn Res,2015,9(8):ED18-19.
[16] Lee CK,Han JM,Lee KN,et al.Concurrent occurrence of chylothorax,chylous ascites,and protein-losing enteropathy in systemic lupus erythematosus. J Rheumatol,2002,29:1330-1333.
[17] Chen GL,Yang DH,Hsu WH.Chylous ascites and pleural transudate:rare presentations in systemic lupus erythematosus in old age. Case Rep Immunol,2012,2012:390831.
[18] Williams AM,Seay TM,Hundley JC,et al.Direct intranodal lymphangiography for recurrent chylous ascites following liver-kidney transplantation. Liver Transpl,2014,20:1275-1276.
[19] Yilmaz M,Akbulut S,Isik B,et al.Chylous ascites after liver transplantation:incidence and risk factors. Liver Transpl,2012,18:1046-1052.
[20] Muela Molinero A,Borrego Galan JC,Quiroga Prado L.Chylous ascites secondary to Whipple disease. Rev Clin Esp,2011,211:e28-e29.
[21] Lippey JF,Yong TL.Chyle leak following biliary pancreatitis. J Surg Case Rep,2014,2014.
[22] Lin WY,Lin GM,Wu CC.Coexistence of non-communicated chylothorax and chylous ascites in nephrotic syndrome. Nephrology,2009,14:700.
[23] Andraus W,Nacif LS,Araujo RL,et al.Chronic pancreatitis associated with chylous ascites simulating liver cirrhosis. Case Rep Surg,2013,2013:763561.
[24] Santos MA,Bose PS,Maher S,et al. Chylous ascites:an unusual complication of necrotizing pancreatitis. Am J Med,2017,130:e151e152.
[25] Cardenas A,Chopra S.Chylous ascites. Am J Gastroenterol, 2002,97:1896-1900.
[26] Chakraborty S,Davis MJ,Muthuchamy M.Emerging trends in the pathophysiology of lymphatic contractile function. Semin Cell Dev Biol,2015,38:55-66.
[27] Tao L,Ning HJ,Nie HM,et al.Diagnostic value of adenosine deaminase in ascites for tuberculosis ascites:a meta-analysis. Diagn Microbiol Infect Dis,2014,79:102-107.
[28] Khandwalla HE,Fasakin Y,El-Serag HB.The utility of evaluating low serum albumin gradient ascites in patients with cirrhosis. Am J Gastroenterol,2009,104:1401-1405.
[29] Bhardwaj R,Vaziri H,Gautam A,et al.Chylous ascites:A review of pathogenesis,diagnosis and treatment. J Clin Transl Hepatol,2018,6(1):105-113.
[30] Al-Busafi SA,Ghali P,Deschênes M,et al.Chylous ascites: Evaluation and management. ISRN Hepatol,2014,2014:240473.
[31] Zhou DX,Zhou HB,Wang Q,et al.The effectiveness of the treatment of octreotide on chylous ascites after liver cirrhosis. Dig Dis Sci,2009,54:1783-1788.
[32] Nunes G,Fonseca C,Barosa R,et al.Idiopathic chylous ascites in a patient with HIV infection:response to total parenteral nutrition and octreotide therapy. Clin J Gastroenterol,2018,11(3):235-239.
[33] 中华医学会肝病学分会.肝硬化腹水及相关并发症的诊疗指南.实用肝脏病杂志,2018,21(1):21-31.
[34] Tsauo J,Shin JH,Han K,et al.Transjugular intrahepatic portosystemic shunt for the treatment of chylothorax and chylous ascites in cirrhosis:a case report and systematic review of the literature. J Vasc Interv Radiol,2016,27:112-116.
[35] Weniger M,D’Haese JG,Angele MK,et al. Treatment options for chylous ascites after major abdominal surgery:a systematic review. Am J Surg,2016,211:206-213.
[36] Pamarthi V,Stecker MS,Schenker MP,et al.Thoracic duct embolization and disruption for treatment of chylous effusions:experience with 105 patients. J Vasc Interv Radiol,2014,25:1398-1404.
[37] Kim J,Won JH.Percutaneous treatment of chylous ascites. Tech Vasc Interv Radiol,2016,19(4):291-298.
[38] Nadolski GJ,Chauhan NR,Itkin M.Lymphangiography and lymphatic embolization for the treatment of refractory chylous ascites. Cardiovasc Intervent Radiol,2018,41(3):415-423.

Current diagnosis and treatment of chylous ascites

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Chen Shuai, Yang Changqing.. Pathogenesis and risk factors of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 761-764.
[2]	Zhang Rui, Wang Jian, Chen Shiyao.. Mechanism of portal vein thrombosis in cirrhotic patients with portal hypertension and the treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 930-933.
[3]	Liang Jubo, Miao Qi, Ma Xiong.. Diagnosis and treatment of cholangiocytic cholestasis [J]. Journal of Practical Hepatology, 2019, 22(6): 941-943.
[4]	Gao Zhiliang, Zhu Xiang. How to achieve the clinical cure of hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 305-308.
[5]	Wang Xiaoxiao, Chen Xinyue. Therapeutic strategy for serum HBsAg clearance in suitable population of chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 309-312.
[6]	Liu Li，Li Junyi，Du Yingrong. Efficacy and safety of sofosbuvir/daclatasvir in the treatment of patients with chronic hepatitis C and hepatitis C cirrhosis:An real-world study [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 361-364.
[7]	Guideline for diagnosis, treatment of liver failure. [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 164-171.
[8]	Zhao Xiaofei, Lin Dongdong, Li Ning, Zang Yunjin, Guo Qingliang, Wu Juanshan. Application of warfarin in dealing with portal vein thrombosis in patients with liver cirrhosis after splenectomy and devascularization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 240-243.
[9]	Zhong Yan, Su Shuting, Mi Yuqiang.. Treatment of patients with nonalcoholic fatty liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 145-148.
[10]	Hu Hulan, Zhu Mengfei, Shi Junping.. Non-alcoholic fatty liver disease with concurrent chronic hepatitis B: What’s the progress [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 149-152.
[11]	Pu Yonglan, Chen Yuanwen, Fan Jiangao.. Gluten intestinal disease and nonalcoholic fatty liver: One case report [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 981-982.
[12]	Cui Ruibing, Yan Ming.. Etiology of ascites:what’s going on [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 657-660.
[13]	Cao Fenghua, Jing Jisheng, Zhao Wei, et al.. Clinical efficacy and safety of large dose of domestic interferon-α2b and ribavirin in the treatment of patients with chronic hepatitis C [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 729-732.
[14]	Cao Haixia, Fan Jiangao. Brief introduction of ESPGHAN recommendation for the diagnosis and treatment of children with Wilson's disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 502-504.
[15]	Zeng Minde. Mechanisms of lipotoxicity in pathogenesis of nonalcoholic fatty liver diseases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 153-156.